- Ph.D., Chemistry, Durham University, England, 2008
- B.Sc., Chemistry, University College Dublin, 2004
- Post-Doctoral Research Associate, Northern Institute of Cancer Research (NICR), University of Newcastle, 2008-2009
Barry Dodd, Ph.D., is a senior managing scientist in Exponent's Chemical Regulation & Food Safety practice with nearly 20 years of experience in biocidal products regulation, chemical regulatory affairs, and market authorization strategy. He specializes in biocidal product authorisations, active substance approvals and renewals, regulatory strategy, product classification, and market access, advising clients on complex scientific and regulatory challenges.
Dr. Dodd offers a broad cross-sector regulatory perspective, with experience spanning biocides, over-the-counter (OTC) medicines, medical devices, cosmetics, pesticides, and plant protection products. His career across government, industry, academia, and consultancy provides first-hand insight into how regulatory requirements are assessed, interpreted, and implemented, enabling him to develop pragmatic strategies for complex and borderline products.
Areas of Expertise
- EU and UK biocides regulation
- Biocidal product authorisation
- Active substance approval and renewal
- Biocide regulatory strategy
- Product classification and borderline products
- Regulatory pathway and market access strategy
- Regulatory authority liaison
- Dossier development and regulatory review
- Mutual recognition and Union authorisation
- Post-authorisation and product lifecycle support
- Analysis of alternatives
- Technical equivalence
EU BPR Regulatory Strategy
Dr. Dodd advises clients on regulatory strategy and market access under the EU Biocidal Products Regulation (BPR), with experience spanning active substance approvals and renewals, product authorisations, mutual recognition, Union authorisation, and post-authorisation requirements. His work covers disinfection, preservation, and pest control, with particular experience in professional hygiene and homecare applications. He helps clients address complex regulatory challenges, develop pragmatic compliance strategies, and achieve and maintain market access throughout the product lifecycle.
Product Classification and Cross-Sector Regulation
Dr. Dodd's experience across biocides, OTC medicines, medical devices, cosmetics, pesticides, and plant protection products provides a broad perspective on product classification and regulatory pathway selection. He advises on complex and borderline products where regulatory status may be unclear or where multiple EU or UK regulatory frameworks may apply.
Regulatory Strategy and Support
Dr. Dodd provides strategic and technical regulatory advice throughout the product lifecycle, helping clients address complex regulatory issues, develop practical compliance strategies, and achieve and maintain market access in European and international markets.
Prior Experience
Dr. Dodd began his regulatory career with the UK Health and Safety Executive's Chemicals Regulation Directorate (HSE CRD), the UK competent authority for biocides and pesticides, where he spent nearly six years as a regulatory scientist. This was followed by an extensive period in industry at Reckitt and Arxada, where he held senior regulatory roles with responsibility for biocides and related regulated products. This combination of regulatory authority and industry experience gives him valuable insight into both the assessment and practical implementation of regulatory requirements. Dr. Dodd holds a Ph.D. in organic chemistry from Durham University.